Dr. Reddy's Lab gets EIR from USFDA for manufacturing plants at Visakhapatnam

13 Sep 2019 Evaluate

Dr. Reddy's Laboratories has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for formulations manufacturing plants at Visakhapatnam. The agency had conducted an audit of the company’s formulations manufacturing plants (Vizag SEZ Plant 1 - FTO 7 and Vizag SEZ Plant 2 - FTO 9) at Duvvada, Visakhapatnam, which was completed on June 21, 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1222.75 14.30 (1.18%)
30-Jan-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1592.00
Dr. Reddys Lab 1222.75
Cipla 1323.50
Zydus Lifesciences 888.20
Lupin 2146.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×